Maverakis, Emanual
Marzano, Angelo V.
Le, Stephanie T.
Callen, Jeffrey P.
Brüggen, Marie-Charlotte
Guenova, Emmanuella
Dissemond, Joachim
Shinkai, Kanade
Langan, Sinéad M.
Article History
Accepted: 13 August 2020
First Online: 8 October 2020
Competing interests
: J.P.C. has ownership of trusts that own stock in Amgen, Pfizer, 3M, Johnson & Johnson, Merck, Abbott Laboratories, AbbVie, Procter and Gamble and Allergen. J.P.C. is a member of a safety monitoring committee for Principia Biopharma. All other authors declare no competing interests.